Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
10-year immune response after primary yellow fever vaccination in elderly travelers
NL-OMON24129Not yet recruiting
- Sponsor
- A.H.E. Roukens en L.G. Visser
- Start
- Oct 2019
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label trial of 17D yellow fever vaccine in yellow fever (2 arms), sponsored by A.H.E. Roukens en L.G. Visser. Primary endpoints: Geometric mean titer of yellow fever neutralizing antibodies and Seroprotection rate. Planned start Oct 2019; status: not yet recruiting.
02
Drugs
17D yellow fever vaccine
03
Conditions
yellow fever
Beyond the preview
Go deeper on NL-OMON24129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24129.